Mustang Bio will undergo 1-for-50 reverse stock split to comply with Nasdaq's bid price requirement.

From GlobeNewswire: 2025-01-14 08:00:00

Mustang Bio, Inc. will undergo a 1-for-50 reverse stock split of its common stock, aiming to comply with Nasdaq’s minimum bid price requirement. The split will reduce outstanding shares from 64.8 million to 1.3 million, with no fractional shares issued. Stockholders can expect a proportional cash payment for any fractional shares. Mustang’s common stock will continue trading on Nasdaq as “MBIO” post-split. The reverse stock split is effective January 16, 2025, and managed by VStock Transfer, LLC. No action is required for stockholders holding shares electronically or through a bank or broker. Additional details can be found in Mustang’s SEC filings.



Read more at GlobeNewswire: Mustang Bio Announces Reverse Stock Split